Evidence map›Paper›PMID 39209607›Full record

ArticleSchizophrenia research2024

Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia.

Paulo Lizano, Rakesh Karmacharya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paulo LizanoDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA; Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA; Division Chief of Translational Neuroscience, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: plizano@bidmc.harvard.edu.
Rakesh KarmacharyaDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA; Chemical Biology Program, Broad Institute of MIT & Harvard, Cambridge, MA, USA; Schizophrenia & Bipolar Disorder Program, McLean Hospital, Belmont, MA, USA.

Funding

Ex vivo signature of psychosis and treatment response in patient-derived neuronsR01MH113858 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI KARMACHARYA, RAKESH · 2017 to 2021
$2.7M
Retinal Layer, Microvascular and Electroretinographic Determinants of Early Course SchizophreniaK23MH122701 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LIZANO, PAULO L · 2021 to 2024
$768k
NIMHD NIH HHS L32 MD014380NIMH NIH HHS K23 MH122701NIMH NIH HHS R01 MH113858
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39209607
PMCPMC11570341

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.